Ratification Date: 01/04/2025
Next Review Date: 01/04/2027
Interferon alfa (Roferon-A®, Viraferon®) – Chronic myelogenous leukaemia
Drug Name (Brand) | Interferon alfa (Roferon-A®, Viraferon®) | |||
Indication | Chronic myelogenous leukaemia | |||
Traffic Light Classification | Red | |||
NICE TA (plus link) | ||||
Further Information:
NICE recommendations, summary of meeting discussions, links to additional supporting docs etc.
January 2013: Commissioned as a Hospital Only treatment by NHS Norfolk & Waveney in line with Cancer Network regimens.
March 2013: The TAG revised the previous Amber classification to Red (Hopistal Only) in line with the current commissioning position.
April 2013: NHS England SCG took over commissioning responsibility for this treatment.
|
||||
Date of TAG recommendation / ratification | 3/1/2013 | Review Date | 1/4/2027 |